Excellent 4.6 out of 5
Solvents & Industrial Byproducts

4-Methylhippuric Acid (4MHA) Environmental Toxin Test

This urine test measures 4‑Methylhippuric Acid (4MHA), a biomarker of p‑xylene (xylene solvent) exposure, helping you catch overexposure early and avoid headaches, dizziness, respiratory irritation, and liver/kidney strain.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for 4-Methylhippuric Acid (4MHA)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to p‑xylene using its urinary metabolite, 4‑methylhippuric acid (4MHA), and how it compares with typical levels.
  • Identify meaningful exposure patterns and potential sources, such as fresh paint or varnish, gasoline fumes during refueling, industrial solvents, adhesives, and permanent markers.
  • Clarify whether xylene exposure could be contributing to symptom clusters like headache, dizziness, throat or eye irritation, or cognitive fatigue.
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages.
  • Track trends over time after changing products, improving ventilation, or modifying occupational tasks.
  • Inform conversations with your clinician about whether broader VOC testing or workplace evaluations are warranted.

What is 4‑Methylhippuric Acid (4MHA)?

4‑Methylhippuric acid is the primary urinary metabolite of p‑xylene, an aromatic hydrocarbon classified as a volatile organic compound (VOC). Xylenes are common in paint thinners, varnishes, certain adhesives, printing and auto shop solvents, gasoline, and some specialty nail or art products. Most everyday exposure occurs by inhaling vapors, with smaller contributions from skin contact or contaminated dust. Laboratories typically measure 4MHA in urine by mass spectrometry and frequently adjust the result for creatinine to account for hydration. Because p‑xylene is metabolized and cleared relatively quickly, urinary 4MHA reflects recent exposure, usually within the past day.

From a biology standpoint, inhaled xylene is absorbed through the lungs, distributed to tissues, and then processed by the liver. Phase I enzymes oxidize it to methylbenzoic acids, which are then conjugated with glycine in Phase II pathways to form methylhippuric acids that are excreted in urine. Xylene is not a persistent chemical; it does not meaningfully bioaccumulate. Health effects of exposure center on the nervous system and mucous membranes, with potential irritation of eyes and airways, and transient neurocognitive symptoms at higher levels. The liver and kidneys handle metabolism and clearance, so sustained high exposure can stress these systems, though typical consumer exposures are far below occupational limits.

Why Is It Important to Test For 4‑Methylhippuric Acid?

If you have ever felt lightheaded while painting a room, caught a strong whiff of gasoline at the pump, or noticed a scratchy throat after a day in a workshop, you have already met the biologic footprint that this test can capture. Xylenes act as solvents in cell membranes and can depress central nervous system activity, which is why headaches, dizziness, or brain fog can show up after intense inhalation. Measuring 4MHA helps distinguish incidental contact from sustained or repeated exposure. A single brief encounter, like walking past fresh paint, can yield a small, short-lived rise, while ongoing tasks in a poorly ventilated space or daily work with solvent-based products often produce a more pronounced and repeatable pattern. Occupational health groups use urinary methylhippuric acids as standard biomarkers of xylene exposure, and the same logic applies at home: numbers over time reveal whether an environment, product, or routine is the driver. Testing is particularly informative if you are pregnant or planning pregnancy, if you work in high-exposure settings such as painting, printing, auto refinishing, or certain beauty services, or if you are sorting out unexplained headaches, irritant symptoms, or end-of-day fatigue that clusters around specific activities.

The larger value of a 4MHA result is context. Xylene often travels with other VOCs like toluene and ethylbenzene in fuels and solvent blends. Your body handles these through related metabolic pathways, so patterns across multiple VOC biomarkers, plus general health indicators like liver and kidney function, tell a clearer story than any one number. Because 4MHA reflects recent exposure, timing matters. A midweek sample during a renovation project is different from a quiet weekend sample. Hydration affects concentration, which is why creatinine correction is commonly used. And 4MHA is specific to p‑xylene; it will not capture exposure dominated by the m‑ or o‑xylene isomers unless those are also measured as 3‑ and 2‑methylhippuric acids. Leaning on trends, symptom diaries, and known exposure windows helps separate signal from noise and supports practical decisions with your clinician, from improving ventilation to considering workplace evaluations when appropriate.

What Insights Will I Get From an 4‑Methylhippuric Acid (4MHA) Test?

Labs typically report urinary 4MHA against a population-based reference range, often with creatinine correction to reduce the impact of dilution. For environmental toxins, lower values are generally preferable when feasible, but interpretation benefits from repeat testing and clear knowledge of recent exposures, such as painting, refueling, or time spent in enclosed garages or workshops.

Relatively lower values usually indicate limited recent contact with p‑xylene, suggesting a low likelihood of short-term irritation or neurologic symptoms attributable to this solvent. In pregnancy and early childhood, where the margin for error is narrower, lower values provide added reassurance that day-to-day environments are not contributing appreciable VOC load.

Relatively higher values can signal recent or ongoing exposure and a potential burden on systems involved in detoxification and clearance, particularly the liver’s Phase I and Phase II pathways and the kidneys’ excretion role. Symptoms, if present, tend to align with xylene’s typical targets: stinging eyes or throat, headaches, lightheadedness, or fatigue after solvent-heavy tasks. Because 4MHA clears quickly, a single elevated result is best confirmed with timing and trends. If values persistently run high during certain activities, that pattern is informative even when general health labs are normal.

Big picture, your environmental toxin results are most meaningful when viewed alongside related VOC metabolites, general health markers, and the lived context of your day. That combination helps distinguish transient spikes from persistent exposure patterns and supports smarter, safer choices with your clinician’s guidance. A brief note on limitations: hydration state and sample timing can shift the number, creatinine correction partially addresses dilution, and measuring only 4MHA reflects p‑xylene rather than the full xylene mixture. Still, as a targeted lens on recent exposure, it is a reliable and widely used biomarker that turns everyday experiences, like the smell of fresh paint, into objective data you can track.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a 4-Methylhippuric Acid (4MHA) test?

This test measures the urinary concentration of 4‑methylhippuric acid, a metabolite and exposure marker of p‑xylene.

Its level reflects recent inhalation or dermal exposure to p‑xylene (common in solvents, paints, and gasoline) and is used in occupational and environmental biomonitoring to estimate recent uptake and metabolism; higher concentrations indicate greater recent exposure.

Should I test for 4-Methylhippuric Acid (4MHA)?

4‑Methylhippuric acid (4MHA) is a urinary metabolite of p‑xylene, a common volatile organic solvent; testing matters because it provides an objective measure of recent xylene exposure, and reducing chronic solvent exposure can help protect brain, liver/kidney, reproductive health and overall long‑term resilience. Potential sources include solvents in paints, coatings, adhesives, printing inks, gasoline and vehicle exhaust; possible health impacts range from short‑term CNS effects (headache, dizziness, nausea) and respiratory irritation to concerns with chronic neurocognitive, hepatic/renal or reproductive effects at higher exposures. Testing helps clarify whether a person has meaningful recent exposure, pinpoints likely environmental or occupational sources, and supports targeted reduction strategies such as improved ventilation, substitution or workplace controls.

Those who benefit most from 4MHA testing include people with high environmental or occupational solvent exposure (painters, printers, petrochemical and fuel‑handling workers), residents near heavy traffic or refineries, individuals with unexplained neurological or respiratory symptoms, people concerned about fertility or endocrine/thyroid issues, and anyone proactively optimizing detox capacity or longevity by reducing avoidable pollutant burdens.

How often should I test for 4-Methylhippuric Acid (4MHA)?

Test once to establish a baseline level of 4‑Methylhippuric Acid (4MHA); if baseline levels are elevated, do periodic follow-up testing (for example, every few weeks to months depending on exposure severity) until levels decline; and always retest after relevant lifestyle or environmental changes—for example, after changing household products, modifying workplace practices, or following detoxification efforts—to confirm exposure reduction.

What can affect 4-Methylhippuric Acid (4MHA) test results?

Factors that may alter 4‑Methylhippuric Acid (4MHA) test results include timing of sample collection (time since exposure and sampling relative to exposure), recent exposures from food, air, water or consumer products that contain the parent compound, individual metabolic differences (age, genetics, liver/kidney function) affecting biotransformation and elimination, hydration status which can concentrate or dilute urinary 4MHA, and the type of sample analyzed (urine versus blood); certain medications or dietary supplements may also influence metabolism or interfere with assay measurements and change readings.

Are there any preparations needed before testing 4-Methylhippuric Acid (4MHA) levels?

Fasting is generally not required for 4‑Methylhippuric Acid (4MHA) urine testing, and a special first‑morning sample is usually not necessary; follow any specific instructions given by the testing laboratory or your clinician.

If possible, avoid nonessential exposure to products or environments that may contain solvents or related chemicals before the test (for example paints, adhesives, gasoline or solvent vapors, certain plastics, some personal care items, and pesticides). Note and report any recent product use or environmental contact (what was used, where, and when) so the clinician can interpret the results in context.

How accurate is 4-Methylhippuric Acid (4MHA) testing?

The 4‑Methylhippuric Acid (4MHA) urine test is a reliable biomarker for recent exposure to its parent compounds; it primarily reflects exposure within the prior hours to a day or two rather than long‑term body burden. When measured with validated assays, 4MHA concentrations track short‑term uptake and metabolism and are useful for assessing whether a recent exposure has occurred, not for estimating cumulative lifetime dose.

Accuracy depends on timing of the sample relative to exposure, the laboratory method used (highest specificity and sensitivity are achieved with validated chromatographic methods coupled to mass spectrometry, e.g., GC‑MS or LC‑MS/MS), and consistency of collection and handling (timed or well‑documented spot samples, creatinine or specific‑gravity normalization, proper storage, and lab quality controls). Biological variability, rapid metabolism, and low‑level exposures near the assay detection limit can also affect interpretation, so results are most reliable when sampling, methods, and reporting are consistent and appropriately contextualized.

What happens if my 4-Methylhippuric Acid (4MHA) levels are outside the optimal or reference range?

High 4‑Methylhippuric Acid (4MHA) levels usually suggest recent or ongoing exposure to xylene-containing substances (common in paints, solvents, fuels, and some industrial environments) or slower removal of the chemical from your body (for example due to liver/kidney issues or individual differences in metabolism). Elevated results can indicate greater body burden and may be associated with exposure-related symptoms, but a high result alone does not prove harm—it's a signal to look for exposure sources and consider protective steps.

Low or below‑reference 4MHA levels generally mean little or no recent exposure or that your body is clearing the compound normally, though timing of the urine sample, laboratory variability, or a missed exposure window can affect results. All results should be interpreted in context — alongside other toxin measurements, your work and home environment, lifestyle, symptoms, and clinical tests — and may warrant repeating the test, exposure reduction measures, and discussion with a healthcare or occupational health professional.

How do I interpret my 4-Methylhippuric Acid (4MHA) test results?

4‑Methylhippuric Acid (4MHA) is a urinary metabolite that primarily indicates recent exposure to p‑xylene (a common solvent); because it is rapidly excreted, results mainly reflect exposures in the prior 24–48 hours. A low or undetectable 4MHA usually means no recent significant exposure, while an elevated value suggests recent xylene contact—interpretation should use the lab’s reference range and, when available, creatinine‑ or specific gravity‑corrected urine results to adjust for dilution.

Interpreting a single result is limited: compare values to prior tests to assess trends over time and to any known exposure events, and always review 4MHA alongside related toxin markers (other methylhippuric isomers or solvent metabolites) and body system indicators such as liver enzymes, kidney function tests, and oxidative‑stress biomarkers. Persistent or rising 4MHA, or elevations with abnormal organ biomarkers or symptoms, warrants workplace exposure review, exposure‑reduction measures, and discussion with occupational health or your clinician for follow‑up testing and management.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start your Women’s Health Check
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you